Schizophrenia is a very dangerous mental disorder. It is a personality disorder where the brain convinces the patient that he is more than one person. This disease has been roaming our plane for a long time and has yet to be understood fully. Many different treatments are out there under the form of untraditional medical treatments. This includes the use of electricity, physical exercises and other forms of psychological sessions.
However, a recent study conducted by a team of scientists from the Vanderbilt University Department of Molecular Physiology and Biophysics and the Vanderbilt Genetics Institute (VGI) was able to identify the gene responsible for the disease to appear.
According to the study, a gene called 104 is a high-risk gene that might cause schizophrenia to develop in humans. The study was published in the journal of Nature Neuroscience. The final results suggest that this disease can actually be developed by a team like any other diseases. Furthermore, scientists believe that it can be treated and prevented before the symptoms appear.
The study was led by PhD holder Bingshan Li who is also an associate professor of Molecular Physiology and Biophysics and an investigator in the Vanderbilt Genetics Institute (VGI). He commented on his findings saying, “This framework opens the door for several (research) directions. I think we’ll have a better understanding of how prenatally these genes predispose risk and that will give us a hint of how to potentially develop intervention strategies. It’s an ambitious goal … (but) by understanding the mechanism, drug development could be more targeted.”